$KEQU

Phillips Elizabeth D sold (to issuer) $181K of KEQU

Phillips Elizabeth D (SVP, People & Culture) sold (to issuer) 4,995 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.18M total) on 2026-06-30.

Original reporting
SEC EDGAR · Phillips Elizabeth D
Published Jul 2, 2026, 3:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 2, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KEQU
Neutral
medium confidence
Mentioned
$KEQU
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEQUNeutralLow
01

Why it matters

The newest fact is the specific insider sale: 4,995 shares at $36.25 on 2026-06-30 under code D, with post-transaction holdings of 9,909 shares.

02

Market read

This provides incremental transparency on insider activity but does not introduce new fundamental catalysts.

03

What to watch

No 10b5-1 plan is cited; however, the transaction code (D) and “sale to issuer” typically reduce interpretive value versus open-market sales.

Relevance 4/10Novelty 3/10Timing: filed 2026-07-02 (after-hours/market close timing not specified)

Background

The article is an SEC Form 4 insider transaction disclosure for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU).

Company-level read

Ticker impact

$KEQUNeutralMedium confidence
Context

SEC Form 4 shows KEQU SVP sold 4,995 shares to the issuer at $36.25 on 2026-06-30, leaving 9,909 shares.

Expected impact

Low likelihood of a near-term price catalyst from this single Form 4 transaction.

Evidence & confidence

The filing is primary-source but describes a modest insider transaction; it does not include new company guidance, contracts, or regulatory actions.

Market effects

No sector read-across; this is an individual insider transaction with no operational disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is to the issuer (often buyback-related), it may reflect mechanical participation rather than bearish insider views.

Key entities

  • KEWAUNEE SCIENTIFIC CORP /DE/

    Subject of the Form 4 insider transaction disclosure (KEQU).

  • Phillips Elizabeth D

    SVP, People & Culture; sold shares to the issuer under SEC Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KEQUMed

Kewanee Scientific To Buy Nycom

Kewaunee Scientific (KEQU) agreed to acquire Nycom, the largest U.S. laboratory dealer. The deal aims to combine Nycom's expertise with Kewaunee's manufacturing for integrated solutions. KEQU shares traded down 1.19% at $32.61.

$KEQUMed

Kewaunee Scientific Announces Agreement to Acquire Nycom, Inc.

Kewaunee Scientific (KEQU) agreed to acquire Nycom, a major lab dealer, for $55M, with $20M in notes, $5M in stock, and the rest in cash. The deal aims to combine Nycom's project expertise with Kewaunee's manufacturing, enhancing lab solutions. Nycom's leadership will join Kewaunee's board and management. The transaction is expected to close in Q4 2027, pending approvals.

$KEQUMed

Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. September 9, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first qu

$KEQUMed

Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prfy26q4earningsrelease.htm EX-99.1 Document Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 23, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ